Back to DANSKE BANK A/S DANSKE BANK A/S

NVAXNVAX

Showing 8 of 10 quarters

Position history for DANSKE BANK A/SDANSKE BANK A/S's holdings in NOVAVAX INC

Yes. Danske Bank holds 811 shares of NVAX (Novavax), worth $7,640, as of its Q2 2026 13F filing. It reduced the position by 6,589 shares (-89.0%) from Q1 2026. Danske Bank has held NVAX in every 13F on record since Q1 2024, 10 quarterly filings.

Current Value

$7,640

Current Shares

811

Total Value Change

-$85,822

Total Shares Change

-6,589

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q2
Latest
Decreased
811
-89.0%
$7,6400.0%$9.42
0
2026-Q1
Unchanged
7,400
0.0%
$60,2360.0%$8.14
0
2025-Q4
Unchanged
7,400
0.0%
$49,7280.0%$6.72
0
2025-Q3
Decreased
7,400
-25.3%
$64,1580.0%$8.67
0
2025-Q2
Unchanged
9,900
0.0%
$62,3700.0%$6.30
0
2025-Q1
Increased
9,900
+33.8%
$63,4590.0%$6.41
27
2024-Q4
Unchanged
7,400
0.0%
$59,4960.0%$8.04
0
2024-Q3
Increased
7,400
+19.4%
$93,4620.0%$12.63
26

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used